UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
| MILESTONE PHARMACEUTICALS INC. |
| (Name of Issuer) |
| Common Shares |
| (Title of Class of Securities) |
| 59935V107 |
| (CUSIP Number) |
| December 31, 2020 |
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ☐ | Rule 13d-1(b) | |
| ☒ | Rule 13d-1(c) | |
| ☐ | Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 59935V107 | SCHEDULE 13G | Page 2 of 5 |
| 1 |
NAME OF REPORTING PERSON
Fonds de solidarité des travailleurs du Québec (F.T.Q.) |
|
| 2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
N/A |
(a) ☐ (b) ☐ |
| 3 |
SEC USE ONLY
|
|
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Montreal (Quebec) Canada |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 |
SOLE VOTING POWER
1,387,393 Common Shares |
| 6 |
SHARED VOTING POWER
N/A | |
| 7 |
SOLE DISPOSITIVE POWER
1,387,393 Common Shares | |
| 8 |
SHARED DISPOSITIVE POWER
N/A |
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,387,393 Common Shares |
|
| 10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
☐ |
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.7% |
|
| 12 |
TYPE OF REPORTING PERSON
IV |
| CUSIP No. 59935V107 | SCHEDULE 13G | Page 3 of 5 |
| Item 1. | (a) | Name of Issuer: |
| Milestone Pharmaceuticals Inc. | ||
| (b) | Address of Issuer’s Principal Executive Offices: | |
|
1111 Dr. Frederik-Philips Boulevard Suite 420 Montreal, Quebec, CANADA H4M 2X6 | ||
| Item 2. | (a) | Names of Person Filing: |
| Fonds de solidarité des travailleurs du Québec (F.T.Q.) | ||
| (b) | Address of Principal Business Office: | |
|
545, Cremazie Blvd. East, Suite 200 Montreal, Quebec, CANADA H2M 2W4 | ||
| (c) | Citizenship: | |
| See row 4 of cover page. | ||
| (d) | Title of Class of Securities: | |
| Common Shares | ||
| (e) | CUSIP Number: | |
| 59935V107 |
| Item 3. | If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: |
| N/A | |
| Item 4. | Ownership. |
The percentage ownership interest is determined based on 29,822,897 Common Shares outstanding as of November 6, 2020, as reported in the Company’s Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on November 13, 2020. |
| (a) | Amount beneficially owned: | |
See row 9 of cover page. | ||
| (b) | Percent of class: | |
|
See row 11 of cover page. |
| CUSIP No. 59935V107 | SCHEDULE 13G | Page 4 of 5 |
| (c) | Number of shares as to which the person has: |
| (i) | Sole power to vote or to direct the vote: | ||
| See row 5 of cover page. | |||
| (ii) | Shared power to vote or to direct the vote: | ||
| See row 6 of cover page. | |||
| (iii) | Sole power to dispose or to direct the disposition of: | ||
| See row 7 of cover page. | |||
| (iv) | Shared power to dispose or to direct the disposition of: | ||
| See row 8 of cover page. |
| Item 5. | Ownership of Five Percent or Less of a Class: |
| If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following. ☒ | |
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person: |
| N/A | |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person: |
| N/A | |
| Item 8. | Identification and Classification of Members of the Group: |
| N/A | |
| Item 9. | Notification of Dissolution of Group: |
| N/A | |
| Item 10. | Certification |
| By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11. |
| CUSIP No. 59935V107 | SCHEDULE 13G | Page 5 of 5 |
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated as of February 11, 2021.
Fonds de solidarité des travailleurs du Québec (F.T.Q.) |
|||
| By: | /s/ Liette Leduc | ||
|
Liette Leduc Senior Director – Legal Affairs |
|||